The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine (Q42721217)

5 November 2017

The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine (English)

1 reference

5 November 2017

I A Sokolova

1 reference

5 November 2017

K C Halling

1 reference

5 November 2017

R B Jenkins

1 reference

5 November 2017

H M Burkhardt

1 reference

5 November 2017

R G Meyer

1 reference

5 November 2017

S A Seelig

1 reference

5 November 2017

W King

1 reference

5 November 2017

language of work or name

1 reference

1 August 2000

1 reference

The Journal of Molecular Diagnostics

5 November 2017

1 reference

5 November 2017

1 reference

5 November 2017

1 reference

5 November 2017

116-123

1 reference

Clinical evaluation of the BTA trak assay and comparison to voided urine cytology and the bard BTA test in patients with recurrent bladder tumors

5 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906906

Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906906

Flow cytometry versus urinary cytology in the diagnosis and follow-up of bladder tumors: critical review of a 5-year experience

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906906

Two molecular pathways to transitional cell carcinoma of the bladder.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906906

Detection of genetic aberrations in bladder cancer using in situ hybridization

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906906

Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906906

The clinical value of urinary cytology: 12 years of experience with 615 patients

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906906

Molecular genetics of bladder cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906906

Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906906

Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906906

The Bard BTA test: its mode of action, sensitivity and specificity, compared to cytology of voided urine, in the diagnosis of superficial bladder cancer.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906906

Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906906

Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906906

Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906906

Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa)

16 August 2018

1 reference

12 December 2020

Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei

1 reference

12 December 2020

Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors

1 reference

12 December 2020

Deletion of the p16 and p15 Genes in Human Bladder Tumors

1 reference

12 December 2020

Partial allelotype of carcinoma in situ of the human bladder

1 reference

12 December 2020

Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study

1 reference

12 December 2020

Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer

1 reference

12 December 2020

Origins and clinical implications of aneuploidy in early bladder cancer

1 reference

12 December 2020

DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH

1 reference

12 December 2020

Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer

1 reference

12 December 2020

Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization

1 reference

12 December 2020

A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder Cancer

1 reference

12 December 2020

Improved detection of recurrent bladder cancer using the bard bta stat test

1 reference

12 December 2020

Bard BTA test compared with voided urine cytology in the diagnosis of recurrent bladder cancer

1 reference

12 December 2020

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma

1 reference

12 December 2020

Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization

1 reference

12 December 2020

Intratumoral heterogeneity in DNA ploidy of bladder carcinomas

1 reference

12 December 2020

Evidence for two bladder cancer suppressor loci on human chromosome 9

1 reference

12 December 2020

A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors

1 reference

12 December 2020

Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer

1 reference

12 December 2020

Comparison of screening methods in the detection of bladder cancer

1 reference

12 December 2020

Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer

1 reference

12 December 2020

Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma. A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes

1 reference

12 December 2020

10.1016/S1525-1578(10)60625-3

Identifiers

DOI

1 reference

5 November 2017

1 reference

5 November 2017

PubMed publication ID

11229514

1 reference